Reuters logo
Eli Lilly and Co's insulin drug receives tentative approval
August 18, 2014 / 10:30 PM / 3 years ago

Eli Lilly and Co's insulin drug receives tentative approval

Aug 18 (Reuters) - The U.S. Food and Drug Administration granted tentative approval for Eli Lilly and Co and Boehringer Ingelheim’s insulin injection that helps control sugar levels in diabetes patients, said Lilly in a statement.

Although the drug, Basaglar, meets all regulatory requirements for approval, it is subject to an automatic stay order of 30 months because of litigation filed by Sanofi SA .

Sanofi, whose top-selling Lantus helps diabetics control blood sugar levels, has brought a lawsuit accusing Lilly of infringing seven patents related to insulin and devices used to deliver it. (Reporting by Anjali Rao Koppala in Bangalore)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below